Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dyskerin is an essential, evolutionarily conserved enzyme that serves as the catalytic subunit of the H/ACA ribonucleoprotein (RNP) complex. It catalyzes pseudouridylation, the most common post-transcriptional modification of RNA, which stabilizes RNA molecules and regulates processes such as ribosome biogenesis and pre-mRNA splicing. As a core component of the H/ACA RNP, dyskerin guides the modification of ribosomal RNA (rRNA) and small nuclear RNA (snRNA), impacting gene expression and translation efficiency. Dyskerin is also a critical component of the telomerase holoenzyme, where it binds to and stabilizes the telomerase RNA component (TERC/hTR), essential for telomere maintenance. Mutations in the DKC1 gene, which encodes dyskerin, cause X-linked dyskeratosis congenita, a multisystem disorder characterized by bone marrow failure, abnormal skin pigmentation, and predisposition to cancer. Dyskerin’s multifaceted roles in RNA modification and telomere biology make it a molecule of significant interest in both basic biology and disease research, though targeting it therapeutically remains challenging due to its essential cellular functions[1][2][3].
no drugs specifically targeting dyskerin yet; potential therapeutic strategies might aim to restore dyskerin function or stabilize telomerase RNA component in dyskeratosis congenita
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dyskerin (None).